Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC
Clinical trial NCT05062837 · UNKNOWN
Trial details
- NCT number
- NCT05062837
- Sponsor
- Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2024-09-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.